SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?


To: Brian Malloy who wrote (1134)1/4/1999 11:35:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 1580
 
PW came out with PFE and MTC updates today. They think that the safety part of the Celebrex and Vioxx labels will be the same, but Vioxx will get a pain indication. Details linked to the COX-2 Inhibitor table under the New Therapeutics section of biocognizance.com



To: Brian Malloy who wrote (1134)1/6/1999 4:39:00 AM
From: Henry Niman  Respond to of 1580
 
Today's Heard on the Street column covers Celebrex. Details linked to COX-2 Inhibitor table in New Therapeutics section of biocognizance.com